{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:40:17Z","timestamp":1759160417779,"version":"3.37.3"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","license":[{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Traditional Chinese Medicine Scientific Research Project of Anhui Health and Family Planning Commission","award":["2016ZY73"],"award-info":[{"award-number":["2016ZY73"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Percutaneous coronary intervention (PCI) is a common treatment method for coronary artery disease (CAD). PCI can cause myocardial ischemia or injury, and lead to major adverse cardiac events (MACEs). Trimetazidine has significant cardioprotective effects and improves endothelial dysfunction and myocardial injury. We will conduct a comprehensive systematic review and meta-analysis to evaluate effect of trimetazidine on incidence of MACE in CAD patients undergoing PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PubMed, Embase, Web of Science, Cochrane Library, the China National Knowledge Infrastructure, Chinese Biomedical Literature Database, and China Science and Technology Journal Database will be searched to collect randomized controlled trials (RCTs) of trimetazidine for CAD patients undergoing PCI. The range of publication time will be from the inception of the database to October 2020 without language limitation. Two reviewers will independently conduct study selection, data extraction and management, and assessment of risk of bias. Any disagreement will be resolved by discussion with the third reviewer. Review Manager Software 5.3 will be used for meta-analysis. The Cochrane risk of bias tool will be used to assess the risk of bias.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>This study will provide a systematic synthesis of current published data to summarize the effect of trimetazidine on incidence of MACE such as stent restenosis, stent thrombosis, new significant coronary stenosis, myocardial infarction, heart failure, and cardiac arrest in CAD patients undergoing PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>This meta-analysis will provide evidence as to whether trimetazidine can reduce incidence of MACE in CAD patients undergoing PCI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Study registration number:<\/jats:title>\n            <jats:p>INPLASY202090083.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022918","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T19:08:00Z","timestamp":1603912080000},"page":"e22918","source":"Crossref","is-referenced-by-count":2,"title":["Effect of trimetazidine on incidence of major adverse cardiac events in coronary artery disease patients undergoing percutaneous coronary intervention"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4933-8435","authenticated-orcid":false,"given":"Kun","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-shui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,30]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(18)30423-9","article-title":"Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data","volume":"391","author":"Head","year":"2018","journal-title":"Lancet"},{"key":"R2-20230916","first-page":"500","article-title":"Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis","volume":"38","author":"Motwani","year":"2017","journal-title":"Eur Heart J"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2018.07.125","article-title":"Sex-related disparities in obstructive coronary artery disease, percutaneous coronary intervention, and mortality in adults with cardiac arrest","volume":"269","author":"John","year":"2018","journal-title":"Int J Cardiol"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/heartjnl-2017-312755","article-title":"Percutaneous coronary intervention for stable coronary artery disease","volume":"105","author":"Al-Lamee","year":"2019","journal-title":"Heart"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/ccd.26970","article-title":"Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease","volume":"90","author":"Mahmoud","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/joic.12272","article-title":"Percutaneous coronary intervention: 2015 in review","volume":"29","author":"Grines","year":"2016","journal-title":"J Interv Cardiol"},{"key":"R7-20230916","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete revascularization with multivessel PCI for myocardial infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N Engl J Med"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ijcard.2017.02.028","article-title":"Effect of remote ischemia or nicorandil on myocardial injury following percutaneous coronary intervention in patients with stable coronary artery disease: a randomized controlled trial","volume":"236","author":"Miyoshi","year":"2017","journal-title":"Int J Cardiol"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jcin.2019.06.053","article-title":"A contemporary definition of periprocedural myocardial injury after percutaneous coronary intervention of chronic total occlusions","volume":"12","author":"Goliasch","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R10-20230916","first-page":"344","article-title":"Predictors of long-term major adverse cardiac events following percutaneous coronary intervention in the elderly","volume":"21","author":"Aghajani","year":"2018","journal-title":"Arch Iran Med"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.acvd.2018.11.008","article-title":"Incidence of major adverse cardiac events in men wishing to continue competitive sport following percutaneous coronary intervention","volume":"112","author":"Guy","year":"2019","journal-title":"Arch Cardiovasc Dis"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0003319718780551","article-title":"Trimetazidine in the prevention of tissue ischemic conditions","volume":"70","author":"Kallistratos","year":"2019","journal-title":"Angiology"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1097\/MD.0000000000001161","article-title":"Role of trimetazidine in ischemic preconditioning in patients with symptomatic coronary artery disease","volume":"94","author":"Costa","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1097\/MJT.0000000000000180","article-title":"Trimetazidine in practice: review of the clinical and experimental evidence","volume":"23","author":"D\u00e9zsi","year":"2016","journal-title":"Am J Ther"},{"key":"R15-20230916","doi-asserted-by":"crossref","first-page":"4230948","DOI":"10.1155\/2019\/4230948","article-title":"Effects of trimetazidine pretreatment on endothelial dysfunction and myocardial injury in unstable angina patients undergoing percutaneous coronary intervention","volume":"2019","author":"Shao","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"R16-20230916","doi-asserted-by":"crossref","first-page":"e0137775","DOI":"10.1371\/journal.pone.0137775","article-title":"Effect of trimetazidine in patients undergoing percutaneous coronary intervention: a meta-analysis","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"R17-20230916","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R18-20230916","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses","volume":"320","author":"Sutton","year":"2000","journal-title":"BMJ"},{"key":"R19-20230916","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T02:03:59Z","timestamp":1694829839000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022918"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2020,10,30]]},"references-count":19,"journal-issue":{"issue":"44","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022918","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,10,30]]}}}